Overview current studies

The Department of Clinical Pharmacology is looking for people between the ages of 18-64 who received a COVID-19 booster vaccination (virus variant JN.1) between 19/09/2024 and 20/10/2024 (e.g. MedUni Vienna vaccination campaign on 24/25 September, 01/02 October). The aim of the study is to analyse the breadth and extent of vaccination protection against different virus variants in the laboratory.

Important exclusion criteria: COVID-19 infection in the last 180 days, immunosuppression

Time required: max. 20 minutes

Procedure: One-time blood sample (max. 10 ml), expense allowance

Link to make an appointment: https://www.eTermin.net/klinpharm

Please take your vaccination certificate with you!

A new drug is currently being tested for its effect on type 2 diabetes patients. Our team is evaluating the effect on weight, blood glucose levels, liver fat content and glycogen (stored glucose).

We are looking for participants (m/f/d):

• Age: between 18 and 65 years,
• Previous illness: type 2 diabetes
• Overweight (BMI 27 to 39.9)
• Non-smokers

Participation is not possible with:

• active insulin therapy
• Taking more than 2 other medications for diabetes in tablet form
• Severe vascular disease
• Type 1 diabetes
• Cancer diagnosis in the last 10 years (exception: light skin cancer)
• Use of preparations for weight reduction
• Contraindications for MRT

Duration of treatment: 25 weeks
Your expenses will be financially compensated